• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Ripple Therapeutics Announces Evaluation and Licensing Agreements with Glaukos

    ACCESSWIRE

    Ripple Therapeutics Collaborates AbbVie To Develop Next-Gen Glaucoma Therapies

    ACCESSWIRE

    Hovione and Ripple Enter Strategic Partnership to Expand Epidel Platform

    PR NEWSWIRE

    Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors

    ACCESSWIRE

    Ripple Announces First Patient Treated in Phase II Trial Evaluating IBE-814

    BIOSPACE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.